OmniaBio
Nikhil Desai has a strong background in quality assurance and compliance within the pharmaceutical industry. With a Master of Science in Pharmaceutical Manufacturing Engineering and a Bachelor of Pharmacy, Nikhil has held various roles such as Quality Associate, Quality Specialist, and Quality Assurance Executive in companies such as OmniaBio, ZYUS, Mylan, Torrent Pharmaceuticals Ltd, J.B. CHEMICALS & PHARMA LTD, and Nice-Pak Products, Inc. Nikhil's experience includes tasks such as computer system validation, quality risk assessment, incident investigation, method validation, stability studies, SOP review, and root cause analysis. Nikhil is well-versed in GMP compliance and has a track record of ensuring quality and regulatory standards are upheld in their work.
This person is not in any teams
OmniaBio
OmniaBio Inc., a subsidiary of CCRM, launched July 1, 2022. OmniaBio is a contract development and manufacturing organization (CDMO) conducting process development and producing gene-modified cells and viral vectors for Phase I clinical trials to commercial-scale manufacturing. OmniaBio is bringing life-saving cell and gene therapies to patients in Canada and around the world.